AHA Scientific Sessions 2026 Abstract · Nov 2, 2026

Testosterone Exacerbates Cardiac Hypertrophy Through Mitochondrial Dynamic Imbalance in Postmenopausal Hypertension

By Su Q, Wang M, Yu J

Background: Postmenopausal hypertension is frequently complicated by cardiac hypertrophy. Sex hormone imbalance, particularly relative testosterone elevation after menopause, has been implicated in adverse cardiac remodeling, but the underlying mitochondrial mechanisms remain incompletely understood. We investigated whether testosterone exacerbates cardiac hypertrophy through mitochondrial dynamic imbalance and clarified the role of the AKT/FoxO1/MUL1-mediated DRP1 SUMOylation pathway. Methods: A combined in vivo and in vitro experimental study was performed. Ovariectomized spontaneously hypertensive rats were treated with testosterone to establish a postmenopausal hyperandrogenic hypertrophy model. Cardiac structure and function were evaluated by echocardiography, histology, and morphometric analysis, and mitochondrial ultrastructure was assessed in cardiac tissue by transmission electron microscopy. Mechanistic studies were conducted in primary cardiomyocytes exposed to dihydrotestosterone. In vitro, mitochondrial morphology and function were assessed using transmission electron microscopy, MitoTracker staining, and measurements of mitochondrial membrane potential, ATP production, and reactive oxygen species. AKT/FoxO1/MUL1 signaling and DRP1 SUMOylation were examined by Western blotting, RT-qPCR, and immunoprecipitation, with genetic modulation applied exclusively in cardiomyocytes. Pharmacological inhibition of mitochondrial fission with Mdivi-1 was evaluated in both models. Results: Testosterone markedly aggravated cardiac hypertrophy and interstitial fibrosis in ovariectomized hypertensive rats, accompanied by impaired cardiac function and mitochondrial ultrastructural abnormalities. In primary cardiomyocytes, dihydrotestosterone induced mitochondrial fragmentation, reduced membrane potential and ATP production, and increased reactive oxygen species generation. These changes were associated with suppressed AKT phosphorylation, enhanced FoxO1 nuclear translocation, increased MUL1 expression, and elevated DRP1 SUMOylation. Genetic modulation of FoxO1 or MUL1 significantly altered DRP1 SUMOylation and mitochondrial morphology. Inhibition of mitochondrial fission with Mdivi-1 ameliorated mitochondrial dysfunction and attenuated cardiomyocyte hypertrophy in vitro, while partially reversing cardiac remodeling in vivo. Conclusions: Testosterone exacerbates cardiac hypertrophy in postmenopausal hypertension by inducing mitochondrial dynamic imbalance. AKT/FoxO1/MUL1-mediated DRP1 SUMOylation represents a key mechanistic link between androgen excess and pathological cardiac remodeling, and targeting excessive mitochondrial fission may provide a potential therapeutic strategy for hypertensive heart disease in postmenopausal women.

doi.org/10.1161/circ.154.suppl_1.6488Mechanisms

AgingResearch.News